FDA — authorised 22 September 2015
- Marketing authorisation holder: TAIHO ONCOLOGY INC
- Status: approved
🇺🇸 Lonsurf in United States
FDA authorised Lonsurf on 22 September 2015
Marketing authorisations
FDA — authorised 22 September 2015
- Application: NDA207981
- Marketing authorisation holder: TAIHO ONCOLOGY
- Local brand name: LONSURF
- Indication: TABLET — ORAL
- Status: approved
Lonsurf in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Lonsurf approved in United States?
Yes. FDA authorised it on 22 September 2015; FDA authorised it on 22 September 2015.
Who is the marketing authorisation holder for Lonsurf in United States?
TAIHO ONCOLOGY INC holds the US marketing authorisation.